Chiu, Yi-Ting https://orcid.org/0000-0001-7257-7755
Deutch, Ariel Y.
Wang, Wei
Schmitz, Gavin P.
Huang, Karen Lu
Kocak, D. Dewran
Llorach, Pierre
Bowyer, Kasey R.
Liu, Bei
Sciaky, Noah
Hua, Kunjie
Chen, Chongguang
Mott, Sarah E.
Niehaus, Jesse
DiBerto, Jeffrey F.
English, Justin
Walsh, Jessica J. https://orcid.org/0000-0001-8466-8451
Scherrer, Grégory https://orcid.org/0000-0002-1983-5126
Herman, Melissa A. https://orcid.org/0000-0002-7260-3439
Wu, Zhuhao https://orcid.org/0000-0002-2471-0555
Wetsel, William C. https://orcid.org/0000-0002-3592-7397
Roth, Bryan L. https://orcid.org/0000-0002-0561-6520
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (DARPA-5822.e003)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R37DA045657)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01Actf MH112205Projectf)
Article History
Received: 12 December 2023
Accepted: 10 June 2026
First Online: 6 August 2026
Ethics
Competing interests: B.L.R. is an advisory board member or co-founder of XyloBio, ImprintBio and Epiodyne. The other authors declare no competing interests.